Endeavor

What Are Bispecifics and How Do They Help Patients With Cancer?

A new class of immunotherapy is giving doctors another way to guide the immune system toward hard to treat cancers

A Mystery Rash, a Diagnosis Delayed

Larry Hart sought answers for years before cutaneous T-cell lymphoma landed him in the ICU

Navigating Survivorship After Bone and Marrow Transplant

Moffitt experts and leukemia survivor share candid insights and support resources

Pickleball Keeps Cancer Survivors on Their Toes, Moffitt Study Shows

Partnership program with YMCA motivated survivors to increase activity, connect with others

Advocating for Patients From Bench to Bedside

Through education, research and advocacy, these women faculty ensure patient experience guides cancer care

Hard-to-Treat Lymphoma Patients Benefit From New Immunotherapy

AZD0486 demonstrates high response rates in relapsed/refractory diffuse large B-cell lymphoma, including patients who failed CAR-T therapy

Lymphoma of the Eye: What You Need to Know

Since symptoms often mimic other issues, early detection is key

FDA Approves New Immunotherapy for Rare Blood Cancer

Lymphir offers a new option for patients with hard-to-treat cutaneous T-cell lymphoma

Can Tattoos Increase Your Cancer Risk?

A new study finds there could be an association between tattoos and lymphoma